Bios Partners

Investments by market, targeted sectors and preferred funding rounds

Name - Bios Partners

Web -

Description -

Investor Type -

Preferred rounds -

Location

biotech - 100%

Bios Partners invested in ONL Therapeutics during a round worth $46,900,000 - 12/24/2020